반응식
[C:1]([C:4]1[CH:9]=[CH:8][C:7]([S:10]([NH2:13])(=[O:12])=[O:11])=[CH:6][CH:5]=1)(=[O:3])[CH3:2].[C:14]([O:18][C:19]([N:21]1[C:29]2[C:24](=[CH:25][CH:26]=[CH:27][CH:28]=2)[CH:23]=[C:22]1[C:30]1[CH:35]=[C:34]([CH:36]=O)[C:33]([O:38][CH3:39])=[CH:32][C:31]=1[O:40][CH3:41])=[O:20])([CH3:17])([CH3:16])[CH3:15]>>[C:14]([O:18][C:19]([N:21]1[C:29]2[C:24](=[CH:25][CH:26]=[CH:27][CH:28]=2)[CH:23]=[C:22]1[C:30]1[CH:35]=[C:34](/[CH:36]=[CH:2]/[C:1](=[O:3])[C:4]2[CH:5]=[CH:6][C:7]([S:10]([NH2:13])(=[O:11])=[O:12])=[CH:8][CH:9]=2)[C:33]([O:38][CH3:39])=[CH:32][C:31]=1[O:40][CH3:41])=[O:20])([CH3:17])([CH3:16])[CH3:15]참가 물질
3
실험 절차
The title compound was prepared by condensing 4-acetyl-benzenesulfonamide (Ex-26A) and 2-(5-formyl-2,4-dimethoxy-phenyl)-indole-1-carboxylic acid tert-butyl ester (Ex-36A) in a similar manner as described in Ex-22. Yellow solid, 40% yield, mp 120–122° C. 1H-NMR (CDCl3) δ 8.01–8.19 (m, 6H), 7.68 (s, 1H), 7.56 (d, J=8 Hz, 1H), 7.46 (d, J=16 Hz, 1H), 7.21–7.35 (m, 2H), 6.53 (d, J=14 Hz, 2H), 5.01 (s, 2H), 4.00 (s, 3H), 3.85 (s, 3H), 1.42 (s, 9H), MS m/z=563 ([M+H]+). HRMS (ES+) Calcd. for C30H30N2O7S: 563.1852. Found: 563.1862.
출처 및 근거
- ORD 기록
- ord-5d7a874c547f4e10bf5fff9813a4f7a7
- 출처 데이터셋
- uspto-grants-2006_08
- 특허 번호
- US07094801B2
연결된 노트
불러오는 중…